ICON Shares Outstanding 2010-2024 | ICLR

ICON shares outstanding history from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • ICON shares outstanding for the quarter ending September 30, 2024 were 0.083B, a 0.57% increase year-over-year.
  • ICON 2023 shares outstanding were 0.083B, a 0.3% increase from 2022.
  • ICON 2022 shares outstanding were 0.082B, a 21.16% increase from 2021.
  • ICON 2021 shares outstanding were 0.068B, a 27.75% increase from 2020.
ICON Annual Shares Outstanding
(Millions of Shares)
2023 83
2022 82
2021 68
2020 53
2019 54
2018 55
2017 55
2016 56
2015 60
2014 63
2013 62
2012 60
2011 61
2010 61
2009 60
ICON Quarterly Shares Outstanding
(Millions of Shares)
2024-09-30 83
2024-06-30 83
2024-03-31 83
2023-12-31 83
2023-09-30 83
2023-06-30 83
2023-03-31 83
2022-12-31 82
2022-09-30 82
2022-06-30 82
2022-03-31 83
2021-12-31 68
2021-09-30 81
2021-06-30 53
2021-03-31 53
2020-12-31 53
2020-09-30 53
2020-06-30 53
2020-03-31 54
2019-12-31 54
2019-09-30 55
2019-06-30 54
2019-03-31 54
2018-12-31 55
2018-09-30 55
2018-06-30 55
2018-03-31 55
2017-12-31 55
2017-09-30 55
2017-06-30 55
2017-03-31 55
2016-12-31 56
2016-09-30 57
2016-06-30 57
2016-03-31 56
2015-12-31 60
2015-09-30 60
2015-06-30 62
2015-03-31 62
2014-12-31 62
2014-09-30 63
2014-06-30 63
2014-03-31 63
2013-12-31 63
2013-09-30 62
2013-06-30 62
2013-03-31 61
2012-12-31 61
2012-09-30 60
2012-06-30 61
2012-03-31 61
2011-12-31 61
2011-09-30 61
2011-06-30 61
2011-03-31 61
2010-12-31 61
2010-09-30 61
2010-06-30 61
2010-03-31 60
2009-12-31 60
2009-09-30 60
2009-06-30 60
2009-03-31 60
Sector Industry Market Cap Revenue
Medical Medical Services $18.679B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00